Most companies, and even policymakers, are betting big on importing international drug prices — but what does that really mean for cancer care in America? In this episode of Value-Based Voices, Jayson Slotnik, JD, MPH, Partner, Health Policy Strategies, Inc., dives into the evolving landscape of drug pricing reforms, unlocking why policies like the Most Favored Nation (MFN) and the Global Benchmark could reshape how medicines reach patients, providers, and payers. You’ll discover how these models aim to lower drug costs by benchmarking against prices from other countries, and why that sparks fierce debate about innovation, access, and the future of American healthcare. Nick Ferreyros, Managing Director, Policy, Advocacy, and Communications, Community Oncology Alliance (COA), and Tim Dube, MPH, Senior Vice President, Policy & Regulatory Affairs, PCMA, unpack the complexities of the Guard and Globe models, revealing how they impact community oncology practices, Medicare, and even the pharmaceutical industry. They break down the technicalities of rebate mechanisms, international price comparisons, and the legal road ahead — all with a sharp focus on what it means for patients facing cancer. This episode explores critical questions: Will these policies truly deliver lower costs without compromising quality? Are they just the beginning of a long legal and political fight? And how might they reshape the innovation landscape in cancer treatment? With perspectives from advocates and industry insiders, you'll see why this isn’t just about policy — it’s about the future of patient care, physician practice, and our healthcare system at large. If you’re navigating the high-stakes world of cancer care reform, this conversation is essential. Resources & Links: • Community Oncology Alliance (COA) • PCMA — Pharmaceutical Care Management Association Connect with the Guests: • Jayson Slotnik • Nick Ferreyros • Tim Dube Contact Value-Based Voices - Follow AVBCC on LinkedIn - View our podcast lineup - Contact us at info@avbcc.org Thanks for listening!
